BioSpace News Archive

BioTalent Canada today released new findings from its most recent bio-economy Labour Market Information (LMI) study. The data in this new brief— The Talent Differential: The case for work-integrated learning in the bio-economy —was collected from a series of three facilitated roundtable discussions, a survey of 573 bio-economy employers in 2020, and an analysis of data from BioTalent Canada’s current wage subsidy progra

NantHealth , Inc. (NASDAQ: NH), a next-generation, evidence-based, personalized healthcare company, presented virtually with NantOmics and ImmunityBio on September 29-30 2020, a session entitled “ Deep-learning image-based tumor, stroma and lymphocytes spatial relationships and clinical featu

Notable , which is redefining cancer treatment by taking a functional approach to precision oncology in hematological cancers, today announced the addition of Dr. Thomas A. Bock to its board of directors. Bock is a recognized life science leader who built four entrepreneurial organizations that created major impact for both patients and investors, achieving leadership in their fields. He successfully spearheade

Shionogi Announces Publication of Two Studies in The Lancet Infectious Diseases Highlighting the Efficacy and Safety of FETROJA ® for the Treatment of Infections Due to Aerobic Gram-negative Bacteria in Adults With Limited Treatment Options Shionogi announces publication of data from two of its clinical trials; APEKS-NP and CREDIBLE-CR in the journal The Lancet Infectious Diseases APEKS-NP demonstrated that FETROJA (cefiderocol) is an effective a

Regulus Therapeutics Inc . (Nasdaq: RGLS) (the “Company” or “Regulus”), a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs, today announced receipt of a total of $5 million in mi

Gamida Cell and Be The Match BioTherapies ® Expand Strategic Collaboration – Organizations to work together to integrate Be The Match BioTherapies’ existing cell therapy infrastructure to manage the supply chain for potential commercialization of omidubicel –

Automated Ionic ® Cells to Pure DNA Low Input Kit consistently recovers up to twice the amount of high-quality nucleic acid from as few as 10 cultured or sorted cells

The Controlled Drugs and Substances Dealer’s Licence will allow Havn Life to supply naturally-derived psilocybin globally to universities, clinical researchers and companies

Option Care Health Inc. (“Option Care Health”) (NASDAQ: OPCH), the nation’s largest independent national provider of home and alternate site infusion services, today announced that the company will release results for its third quarter ended September 30, 2020 on Tuesday, November 3, 2020

WishBone Medical, Inc., a leader in pediatric orthopedic medical devices, today announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance on their Smart Correction ® External Fixation System, which comprises hexapod external fixator hardware and proprietary planning software. Used in facilities across Asia and Europe since 2009, the System boasts a proven record of higher accuracy [compared to Ilizarov fixators] and a de